The current coronavirus disease 2019 (COVID-19) vaccines are used to prevent viral infection by inducing neutralizing antibody in the body, but according to the existing experience of severe acute respiratory syndrome coronavirus (SARS) infection, T-cell immunity could provide a longer durable protection period than antibody. The research on SARS-CoV-2-specific T-cell epitope can provide target antigen for the development and evaluation of COVID-19 vaccines, which is conducive to obtain COVID-19 vaccine that can provide long-term protection. For screening specific T-cell epitopes, a SARS-CoV-2 S protein peptide library with a peptide length of 15 amino acids was synthesized. Through flow cytometry to detect percentage of IFN-γ + T cells after mixed COVID-19 convalescent patients’ peripheral blood mononuclear cell with peptide library, seven peptides (P77, P14, P24, P38, P48, P74, and P84) that can be recognized by the T cells of COVID-19 convalescent patients were found. After excluding the nonspecific cross-reactions with unexposed population, three SARS-CoV-2-specific T-cell potential epitopes (P38, P48, and P84) were finally screened with the positive reaction rates between 15.4% and 48.0% in COVID-19 convalescent patients. This study also provided the HLA allele information of peptide-positive-response COVID-19 convalescent patients, thus predicting the population coverage of these three potential epitopes. Some HLA alleles showed higher frequency of occurrence in COVID-19 patients than in total Chinese population but no HLA alleles related to the T-cell peptide response and the severity of COVID-19. This research provides three potential T-cell epitopes that are helpful for the design and efficacy evaluation of COVID-19 vaccines. The HLA information provided by this research supplies reference significance for subsequent research such as finding the relation of HLA genotype with disease susceptibility.
【저자키워드】 SARS-CoV-2, Spike protein, HLA, T-cell epitope, cross-reaction, 【초록키워드】 COVID-19, coronavirus disease, neutralizing antibody, viral infection, Coronavirus disease 2019, Efficacy, Vaccine, coronavirus, COVID-19 vaccine, antibody, T cells, susceptibility, Infection, peptide, severe acute respiratory syndrome Coronavirus, flow cytometry, Antigen, Peripheral blood, Epitopes, T cell, Convalescent patients, COVID-19 vaccines, Coverage, Viral, severity of COVID-19, Research, Genotype, peptides, amino acids, T-cell, respiratory, convalescent, information, T-cell epitopes, epitope, disease, IFN-γ, T-cell immunity, SARS-CoV-2 S protein, Amino acid, Frequency, COVID-19 patient, disease susceptibility, frequency of occurrence, mononuclear cell, acute respiratory syndrome, Reactions, reaction rate, acute respiratory syndrome coronavirus, HLA alleles, Chinese, HLA allele, positive, Prevent, COVID-19 convalescent patients, Seven, Occurrence, detect, subsequent, provided, screened, provide, COVID-19 convalescent patient, nonspecific, 【제목키워드】 COVID-19, spike, Specific, Potential, Identified,